K+S Aktiengesellschaft (SDF) | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Headlines Articles Press releases K+S Aktiengesellschaft

Home
Companies
K+S Aktiengesellschaft

BRIEF

published on 10/23/2024 at 10:56, 28 days 23 hours ago

K+S Aktiengesellschaft Announces Leadership Change

Leadership Transition K+S Aktiengesellschaft Board Of Executive Directors Dr. Burkhard Lohr Dr. Christian H. Meyer
PRESS RELEASE

published on 10/23/2024 at 10:51, 28 days 23 hours ago

EQS-Adhoc: K+S Aktiengesellschaft: Change of Chairmanship on the BoED of K+S: Dr. Burkhard Lohr hands over Chairmanship of the BoED to Dr. Christian H. Meyer (CFO) in May 2025
Dr. Burkhard Lohr to retire as Chairman of the Board of Executive Directors at K+S Aktiengesellschaft, with Dr. Christian H. Meyer set to take over in June 2025

Chairmanship Retirement K+S Aktiengesellschaft Dr. Burkhard Lohr Dr. Christian H. Meyer
BRIEF

published on 04/30/2024 at 10:23, 6 months 21 days ago

K+S Aktiengesellschaft Reports Surge in Q1 2024 Financial Results, Maintains Annual Forecast

Financial Performance Q1 2024 Market Expectations Annual Forecast K+S Aktiengesellschaft
PRESS RELEASE

published on 04/30/2024 at 10:18, 6 months 21 days ago

EQS-Adhoc: K+S Aktiengesellschaft: EBITDA and adjusted free cash flow in the first quarter of 2024 significantly above market expectations; Forecast for the full year 2024 unchanged
K+S Aktiengesellschaft reports significantly higher EBITDA and adjusted free cash flow in Q1 2024, exceeding market expectations. Full year 2024 forecast remains unchanged

EBITDA Forecast Free Cash Flow Q1 2024 K+S Aktiengesellschaft
PRESS RELEASE

published on 07/26/2023 at 16:22, 1 year 3 months ago

EQS-Adhoc: K+S Aktiengesellschaft: Quarter Results / Forecast
PRESS RELEASE

published on 06/14/2023 at 11:51, 1 year 5 months ago

EQS-Adhoc: K+S Aktiengesellschaft: Achievability of forecast key figure ranges unlikely due to recent potash price movements
PRESS RELEASE

published on 03/14/2023 at 14:37, 1 year 8 months ago

EQS-Adhoc: K+S Aktiengesellschaft: K+S resolves to return capital to shareholders of up to a total of EUR 391.4 million or about EUR 2 per share (Vara consensus estimate: EUR 1.50 per share)

Accesswire

Published on 11/21/2024 at 10:03, 40 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 43 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 43 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 8 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 18 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 12 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 38 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 40 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 42 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 42 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 45 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 23 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 58 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 58 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE